A detailed history of Portland Global Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Portland Global Advisors LLC holds 23,153 shares of AMGN stock, worth $7.39 Million. This represents 0.98% of its overall portfolio holdings.

Number of Shares
23,153
Previous 22,949 0.89%
Holding current value
$7.39 Million
Previous $6.52 Million 10.88%
% of portfolio
0.98%
Previous 0.92%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$262.75 - $319.31 $53,601 - $65,139
204 Added 0.89%
23,153 $7.23 Million
Q1 2024

May 08, 2024

SELL
$268.87 - $324.56 $79,854 - $96,394
-297 Reduced 1.28%
22,949 $6.52 Million
Q4 2023

Feb 13, 2024

BUY
$255.7 - $288.46 $46,026 - $51,922
180 Added 0.78%
23,246 $6.7 Million
Q3 2023

Nov 13, 2023

BUY
$218.65 - $271.46 $92,926 - $115,370
425 Added 1.88%
23,066 $6.2 Million
Q2 2023

Aug 11, 2023

BUY
$214.27 - $253.37 $205,699 - $243,235
960 Added 4.43%
22,641 $5.03 Million
Q1 2023

May 09, 2023

BUY
$225.79 - $275.2 $271,851 - $331,340
1,204 Added 5.88%
21,681 $5.24 Million
Q4 2022

Feb 01, 2023

SELL
$229.03 - $291.01 $244,604 - $310,798
-1,068 Reduced 4.96%
20,477 $5.38 Million
Q3 2022

Oct 27, 2022

BUY
$224.46 - $253.15 $7,407 - $8,353
33 Added 0.15%
21,545 $4.86 Million
Q2 2022

Jul 27, 2022

BUY
$230.71 - $256.74 $56,293 - $62,644
244 Added 1.15%
21,512 $5.23 Million
Q1 2022

May 10, 2022

BUY
$219.27 - $242.57 $162,479 - $179,744
741 Added 3.61%
21,268 $5.14 Million
Q4 2021

Feb 10, 2022

BUY
$198.88 - $227.6 $266,896 - $305,439
1,342 Added 7.0%
20,527 $4.62 Million
Q3 2021

Oct 13, 2021

BUY
$212.27 - $248.7 $251,964 - $295,206
1,187 Added 6.6%
19,185 $4.08 Million
Q2 2021

Aug 10, 2021

BUY
$233.58 - $259.14 $156,031 - $173,105
668 Added 3.85%
17,998 $4.39 Million
Q1 2021

May 11, 2021

BUY
$221.91 - $258.6 $42,384 - $49,392
191 Added 1.11%
17,330 $4.31 Million
Q4 2020

Feb 08, 2021

BUY
$216.38 - $257.67 $27,047 - $32,208
125 Added 0.73%
17,139 $3.94 Million
Q3 2020

Nov 10, 2020

SELL
$234.65 - $260.95 $51,623 - $57,409
-220 Reduced 1.28%
17,014 $4.32 Million
Q2 2020

Jul 23, 2020

BUY
$197.81 - $242.74 $15,824 - $19,419
80 Added 0.47%
17,234 $4.07 Million
Q1 2020

May 05, 2020

SELL
$182.24 - $241.7 $133,764 - $177,407
-734 Reduced 4.1%
17,154 $3.48 Million
Q4 2019

Jan 29, 2020

SELL
$189.21 - $243.2 $71,710 - $92,172
-379 Reduced 2.07%
17,888 $4.31 Million
Q3 2019

Oct 22, 2019

BUY
$174.11 - $208.62 $13,058 - $15,646
75 Added 0.41%
18,267 $3.54 Million
Q2 2019

Jul 26, 2019

BUY
$166.7 - $195.41 $522,271 - $612,219
3,133 Added 20.8%
18,192 $3.35 Million
Q1 2019

Apr 15, 2019

BUY
$180.87 - $203.88 $22,066 - $24,873
122 Added 0.82%
15,059 $2.86 Million
Q4 2018

Jan 23, 2019

BUY
$178.4 - $208.25 $50,487 - $58,934
283 Added 1.93%
14,937 $2.91 Million
Q3 2018

Oct 23, 2018

BUY
$185.29 - $208.89 $5,002 - $5,640
27 Added 0.18%
14,654 $3.04 Million
Q2 2018

Jul 31, 2018

BUY
$166.05 - $186.51 $34,206 - $38,421
206 Added 1.43%
14,627 $2.7 Million
Q1 2018

May 04, 2018

SELL
$169.43 - $198.0 $57,436 - $67,122
-339 Reduced 2.3%
14,421 $2.46 Million
Q4 2017

Feb 01, 2018

SELL
$168.79 - $188.59 $35,445 - $39,603
-210 Reduced 1.4%
14,760 $2.57 Million
Q3 2017

Nov 01, 2017

BUY
$167.29 - $191.0 $2.5 Million - $2.86 Million
14,970
14,970 $2.79 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Portland Global Advisors LLC Portfolio

Follow Portland Global Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Portland Global Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Portland Global Advisors LLC with notifications on news.